Literature DB >> 11677084

CD4(+) regulatory T cells.

S Read1, F Powrie.   

Abstract

There is now compelling evidence that CD4(+) T cells that specialize in the suppression of immune responses play a key role in the control of immune pathology. Recently, there have been a number of reports that have provided information on the generation of CD4(+) regulatory T cells in the thymus and in the periphery. These cells have also been identified in humans, paving the way for analysis of the function of CD4(+) regulatory T cells in immune-mediated disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11677084     DOI: 10.1016/s0952-7915(01)00273-4

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  38 in total

1.  Localization of FOXP3-positive cells in renal cell carcinoma.

Authors:  Katharina Sell; Peter J Barth; Roland Moll; Martin A Thomas; Nadine Zimmer; Ecatarina Oplesch; Michael Gudo; Mark Schrader; Rainer Hofmann; Andres Jan Schrader
Journal:  Tumour Biol       Date:  2011-12-06

Review 2.  The role of regulatory T cells in allergy.

Authors:  Maria A Curotto de Lafaille; Juan J Lafaille
Journal:  Springer Semin Immunopathol       Date:  2003-10-22

3.  Oral tolerance in the absence of naturally occurring Tregs.

Authors:  Daniel Mucida; Nino Kutchukhidze; Agustin Erazo; Momtchilo Russo; Juan J Lafaille; Maria A Curotto de Lafaille
Journal:  J Clin Invest       Date:  2005-06-02       Impact factor: 14.808

4.  Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells.

Authors:  Jens Dannull; Zhen Su; David Rizzieri; Benjamin K Yang; Doris Coleman; Donna Yancey; Aijing Zhang; Philipp Dahm; Nelson Chao; Eli Gilboa; Johannes Vieweg
Journal:  J Clin Invest       Date:  2005-11-23       Impact factor: 14.808

5.  Tolerance induction after specific immunotherapy with pollen allergoids adjuvanted by monophosphoryl lipid A in children.

Authors:  M Rosewich; J Schulze; O Eickmeier; T Telles; M A Rose; R Schubert; S Zielen
Journal:  Clin Exp Immunol       Date:  2010-03-16       Impact factor: 4.330

6.  T cells and stromal fibroblasts in human tumor microenvironments represent potential therapeutic targets.

Authors:  Jennifer L Barnas; Michelle R Simpson-Abelson; Sandra J Yokota; Raymond J Kelleher; Richard B Bankert
Journal:  Cancer Microenviron       Date:  2010-03-31

7.  Induction of antigen-specific regulatory T cells following overexpression of a Notch ligand by human B lymphocytes.

Authors:  Stéphane Vigouroux; Eric Yvon; Hans-Joachim Wagner; Ettore Biagi; Gianpietro Dotti; Uluhan Sili; Cecilia Lira; Cliona M Rooney; Malcolm K Brenner
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

8.  The influence of partial or total thymectomy during open heart surgery in infants on the immune function later in life.

Authors:  J H Eysteinsdottir; J Freysdottir; A Haraldsson; J Stefansdottir; I Skaftadottir; H Helgason; H M Ogmundsdottir
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

9.  Memory CD4+ T cells do not induce graft-versus-host disease.

Authors:  Britt E Anderson; Jennifer McNiff; Jun Yan; Hester Doyle; Mark Mamula; Mark J Shlomchik; Warren D Shlomchik
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

10.  Aberration of CCR7 CD8 memory T cells from patients with systemic lupus erythematosus: an inducer of T helper type 2 bias of CD4 T cells.

Authors:  Yang Sen; Hu Chunsong; Huang Baojun; Zhang Linjie; Li Qun; Jiang San; Zhang Qiuping; Liu Junyan; Xuejun Zhang; Tan Jinquan
Journal:  Immunology       Date:  2004-06       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.